| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/23/2004 | US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 12/23/2004 | US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
| 12/23/2004 | US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis |
| 12/23/2004 | US20040260088 Novel compounds |
| 12/23/2004 | US20040260084 Having an acceptable side chain radical bonded to the 3 position of the cephalosporin ring by an aminomethylthio- or an oxymethylthio- group, e.g., (6R,7R)-(3-methoxymethylthio-8-oxo-7(-2-phenylacetamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene)-2-carboxylic acid |
| 12/23/2004 | US20040259959 Administering drug to reduce activity to cells with lycopene to remove melanomas |
| 12/23/2004 | US20040259958 Reducing microorganisms with phenols for substrates in a fluid environment for mouthwashes, dentifrices, chewing gum or lozenges |
| 12/23/2004 | US20040259957 Compounds for treatment of cancer, prodrugs |
| 12/23/2004 | US20040259956 Adimistering analgesics by titration for dosage using tramadol and kits |
| 12/23/2004 | US20040259955 Drugs with expectorant of ambroxol or bromhexine for antichlinergic composition |
| 12/23/2004 | US20040259954 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 12/23/2004 | US20040259953 Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
| 12/23/2004 | US20040259952 Formulations for oral administration of cromolyn sodium |
| 12/23/2004 | US20040259949 Aminolevulinulic acid/5-/ and derivatives for healing wounds with heat and photosensitizers for ulcers |
| 12/23/2004 | US20040259948 Liver receptors as antiinflammatory agents and for immunity with administering agonist |
| 12/23/2004 | US20040259947 Edible food and beverage with glycerol, triesters for menstrual problems |
| 12/23/2004 | US20040259945 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 12/23/2004 | US20040259944 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 12/23/2004 | US20040259942 Modulation of stat activity |
| 12/23/2004 | US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 12/23/2004 | US20040259940 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram |
| 12/23/2004 | US20040259939 Dissolving and precipitation a solution of citalopram in acid with solvent, adding base to liberate free base. |
| 12/23/2004 | US20040259938 Novel dipheylenthylene compounds |
| 12/23/2004 | US20040259937 Hydroxycitric acid complex metal salts, composition, and methods |
| 12/23/2004 | US20040259936 Patients in need of anticancer treatment or treatment of lymphomas or autoimmune disease |
| 12/23/2004 | US20040259934 Administering a nucleoside and replication of Coronaviricide infections and duplication of virus |
| 12/23/2004 | US20040259933 Process for producing levetiracetam |
| 12/23/2004 | US20040259932 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| 12/23/2004 | US20040259931 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 12/23/2004 | US20040259929 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 12/23/2004 | US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/23/2004 | US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 12/23/2004 | US20040259926 carbocyclic sulfides such as {4-[5-Methoxy-6-methyl-2-(2H-tetrazol-5-ylcarbamoyl)-benzo[b]thiophene-3-yloxy]-phenyl}-acetic acid ethyl ester, used as phosphatidyl inositol 3-kinase inhibitors; antiinflammatory and anticarcinogenic agents; prophylaxis of cardiovascular disorders |
| 12/23/2004 | US20040259925 Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 12/23/2004 | US20040259924 A metabolite of repinotan hydrochloride that have high affinity for binding to the serotonin receptors of the 5-HT1A type; treating stroke or skull-brain trauma; anxiolytic agents; antidepressants; sexual, sleep and food disorders |
| 12/23/2004 | US20040259923 Compound useful as cellular adhesion protein and as antiedemic agent |
| 12/23/2004 | US20040259922 Epothilone derivatives, a process for their production thereof and their use |
| 12/23/2004 | US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis |
| 12/23/2004 | US20040259920 Acne treatment |
| 12/23/2004 | US20040259919 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders |
| 12/23/2004 | US20040259918 treatment of diabetes mellitus with compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists |
| 12/23/2004 | US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 12/23/2004 | US20040259916 N-[4-(cyanocyclobutyl)-phenyl]{2-[(4-pyridylmethyl)amino]phenyl}carboxamidefor example; inhibit the effect of VEGF receptor tyrosine kinase; use treating cancer, diabetes, and angiogenesis |
| 12/23/2004 | US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259911 Quinoline derivatives process of synthesis and medicaments containing these derivatives |
| 12/23/2004 | US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides |
| 12/23/2004 | US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 12/23/2004 | US20040259907 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents |
| 12/23/2004 | US20040259906 Methods for controlling the proliferation of cells |
| 12/23/2004 | US20040259905 stable, less irritant and easily administrable; high concentration of sulfodehydroabietic acid or salt ion at pH of 7-8.5 in a buffer of a polyphosphate salt or polycarboxylic acid salt such as trisodium citrate and an inorganic base such as sodium hydroxide; for inflammatory bowel disease treatment |
| 12/23/2004 | US20040259902 Dipeptidyl aminopeptidase inhibitors; antidiabetic agents for type 2 diabetes; 2-amino-3-(substituted phenyl-, pyridyl- or pyrrolyl-)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline compounds |
| 12/23/2004 | US20040259900 PARP (poly(adenosine 5'-diphospho-ribose) polymerase) inhibitors; derivatives having a piperazinylsulfonyl group attached to the fused ring |
| 12/23/2004 | US20040259899 in patients who are refractory to laxative and stool softener treatment, such as cancer patients on opioids such as morphine, using an opioid antagonist such as methylnaltrexone and a laxative and/or stool softener |
| 12/23/2004 | US20040259898 Use of methylnaltrexone in treating gastrointestinal dysfunction in equines |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259896 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
| 12/23/2004 | US20040259895 Oral formulation of lipid soluble thiamine and lipoic acid |
| 12/23/2004 | US20040259894 inhibitors of cyclin-dependent kinases (CDKs); cancer, leukemia, psoriasis |
| 12/23/2004 | US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases |
| 12/23/2004 | US20040259892 c-kit inhibitor; unable to promote death of IL-3 dependent cells cultured in presence of IL-3; N-phenyl-2-pyrimidine-amine derivatives; 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2 ylamino)phenyl]-benzamide |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
| 12/23/2004 | US20040259889 Vasconstriction ; administering adenosine receptor antagonist |
| 12/23/2004 | US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease |
| 12/23/2004 | US20040259887 Cannabinoid receptor ligands and uses thereof |
| 12/23/2004 | US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 12/23/2004 | US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one |
| 12/23/2004 | US20040259882 E.g., 2-tert-butyl-4-(4-(3-(4-methyl-5-methyl-4H-(1,2,4)-triazol-3-ylsulfanyl) -propyl)piperazin-1-yl)-6-tert-butyl-pyri midine; high affinities; central nervous system disorders schizophrenia; antidepressants; Parkinson's and Alzheimer's |
| 12/23/2004 | US20040259881 Nitrogenous heterocyclic compounds |
| 12/23/2004 | US20040259880 Cardiovascular disorders; antiproliferative agents; antiinflammatory agents; vision defects; strojkes; administering phosphodiesterase inhibitor |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259878 Noninvasive monitoring tumor tissue concentration of an anticarcinogenic agent in real time using magnetic resonance spectroscopy of these nontoxic compounds to determine the sensitivity of or resistance of a tumor to methotrexate; predicting the efficacy of methotrexate therapy and planning strategy |
| 12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
| 12/23/2004 | US20040259876 Bicyclic compound, production and use thereof |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259873 For treating, preventing and managing various disease or disorders such as central nervous system (CNS) disorders; myelodysplastic syndrome (MDS) and related syndromes; complex regional pain syndrome (CRPS) and related syndromes; cancer |
| 12/23/2004 | US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 12/23/2004 | US20040259870 Antidiabetic agents; obesity; controlling appetite |
| 12/23/2004 | US20040259869 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/23/2004 | US20040259866 Calcium channel blockers comprising two benzhydril moieties |
| 12/23/2004 | US20040259865 Laxative; adenosine receptor antagonist |
| 12/23/2004 | US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259862 Method of treating functional bowel disorders |
| 12/23/2004 | US20040259861 Antiischemic agents |
| 12/23/2004 | US20040259860 Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
| 12/23/2004 | US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders |
| 12/23/2004 | US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 12/23/2004 | US20040259857 Hypotensive agents; dysmenorrhea; antiischemic agents; liver cirrhosis; kidney diseases; liver disorders; strokes; cantral nervous system disorders |
| 12/23/2004 | US20040259856 Fermentation product of marine actinomyces strains; antiproliferative agents; anticancer agents |
| 12/23/2004 | US20040259855 Methods and devices for epithelial protection during photodynamic therapy |
| 12/23/2004 | US20040259854 Methods and devices for epithelial protection during photodynamic therapy |
| 12/23/2004 | US20040259853 Atherosclerosis; cardiovascular disorders; anticholesterol agents; administering an amphilic compound which prevents transferring of cholesterol |
| 12/23/2004 | US20040259852 Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
| 12/23/2004 | US20040259851 Methods of administering estrogens and progestins |
| 12/23/2004 | US20040259850 Method for treating or preventing symptoms of hormonal variation including hot flashes |
| 12/23/2004 | US20040259849 17Alpha-hydroxy-14Beta-steroids with hormonal effect |
| 12/23/2004 | US20040259846 Desolventizing by spray drying; bone disorders, osteoporosis; Paget's disease; osteoarthritis |